›› 2013, Vol. 33 ›› Issue (1): 8-12.

• 基础与临床研究 • 上一篇    下一篇

口腔鳞癌中趋化因子受体CXCR4和CCR7表达及其与临床病理特征的关系

尹东   

  1. 宁夏回族自治区人民医院
  • 收稿日期:2012-05-14 修回日期:2012-07-17 出版日期:2013-01-29 发布日期:2013-02-05
  • 通讯作者: 尹东 E-mail:yindongnx@163.com
  • 基金资助:
    宁夏自然科学基金

Expression of chemokine receptor CXCR4 and CCR7 in oral squamous cell carcinoma and their relation to clinicopathological characteristics

  • Received:2012-05-14 Revised:2012-07-17 Online:2013-01-29 Published:2013-02-05

摘要: 目的 检测CXC类趋化因子受体4(chemokine CXC motif receptor4,CXCR4)和CC类趋化因子受体7(chemokine CC motif receptor7,CCR7)在口腔鳞癌(oral squamous cell carcinoma,OSCC)中表达,探讨其与口腔鳞癌临床病理特点及颈淋巴结转移的关系。方法 采用免疫组化和反转录聚合酶链反应(RT-PCR)检测64例口腔鳞癌组织原发灶、39例转移淋巴结组织和10例正常口腔黏膜组织中CXCR4及CCR7的表达,并分析其与临床病理参数的关系。结果 口腔鳞癌组织细胞中CXCR4、CCR7蛋白的阳性表达率分别为62.5%、65.60%,明显高于正常口腔黏膜组织细胞(P<0.01),其中有淋巴结转移组表达率分别为74.36%、84.62%,无淋巴结转移组表达率分别为44%、36%,差异均有统计学意义(P<0.05),而CXCR4、CCR7在淋巴结转移灶中的阳性表达率差异无统计学意义(P>0.05)。RT-PCR检测结果也证实,CXCR4及CCR7在口腔鳞癌细胞中均有阳性表达。此外,CXCR4及CCR7的表达与肿瘤的分化程度、侵袭程度和TNM分期密切相关(P<0.05),而与年龄、性别和肿瘤大小无关(P>0.05)。结论 趋化因子受体CXCR4、CCR7的表达与口腔鳞癌侵袭发展和淋巴结转移密切相关。CXCR4、CCR7有可能成为口腔鳞癌治疗的新靶点。

关键词: 口腔鳞癌, CXC类趋化因子受体4, CC类趋化因子受体7, oral squamous cell carcinoma, CXC chemokine receptor 4, CC chemokine receptor 7

Abstract: Abstract: Objective To examine the expression of CXCR4 and CCR7 in oral squamous cell carcinoma (OSCC), and to evaluate the relationship between their expression and the clinicopathology factors, as well as lymph node metastasis of OSCC. Methods The expression of CXCR4 and CCR7 in 64 cases of primary tumor tissues of OSCC、39 cases of regional lymph nodes metastasis and 10 cases of normal oral mucous tissue were examined by immunohistochemical technique and RT-PCR. and their relation to cliniopathological parameters was also analyzed. Results In the tumor cells of OSCC, positive expression rates of CXCR4 and CCR7 protein were 62.5% and 65.6%,respectively, and both were significantly higher than those in normal oral mucous tissue(P<0.01). The positive expression rates of CXCR4 and CCR7 in cases with lymph node metastasis were 74.36% and 84.62%, respectively, but those in cases without lymph node metastasis were 44.00% and 36.00%, respectively. The positive expression was significantly higher in patients with lymph node metastasis than that in patients without lymph node metastasis (P<0.05). In regional metastasized lymph nodes, positive expression rates of CXCR4 and CCR7 were no significantly different (P>0.05). RT-PCR also confirmed the presence of positive CXCR4 and CCR7 expression in OSCC. Moreover, CXCR4 and CCR7 expression was correlated with tumor histological type (P<0.05), depth of tumor invasion(P<0.05),and TNM stage (P<0.01), but not with age at surgery, gender, and tumor size. Conclusion CXCR4 and CCR7 expression was correlated with the diverse progression of OSCC, including invasion and lymph node metastasis. CXCR4 or CCR7 may become a potential therapeutic target in advanced cases of OSCC.

中图分类号: